2015
DOI: 10.1016/j.bbrc.2014.12.111
|View full text |Cite
|
Sign up to set email alerts
|

Lysosomal integral membrane protein type-2 (LIMP-2/SCARB2) is a substrate of cathepsin-F, a cysteine protease mutated in type-B-Kufs-disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 39 publications
0
7
1
Order By: Relevance
“…LIMPII regulates endosomal biogenesis and alters prostate cells, and investigating these biomarkers may be a novel method to aid in the diagnosis and prognosis of prostate cancer [39]. Recently, it has been shown that many lysosomal membrane proteins undergo proteolysis, which is mainly mediated by cathepsin proteases like cathepsin-F, indicating lysosomal LIMPII as substrate of cathepsin-F [40]. However, in this study, an increased expression of CD36 and decreased expression of LIMPII was observed.…”
Section: Discussioncontrasting
confidence: 58%
“…LIMPII regulates endosomal biogenesis and alters prostate cells, and investigating these biomarkers may be a novel method to aid in the diagnosis and prognosis of prostate cancer [39]. Recently, it has been shown that many lysosomal membrane proteins undergo proteolysis, which is mainly mediated by cathepsin proteases like cathepsin-F, indicating lysosomal LIMPII as substrate of cathepsin-F [40]. However, in this study, an increased expression of CD36 and decreased expression of LIMPII was observed.…”
Section: Discussioncontrasting
confidence: 58%
“…To date, nine mutations with recessive inheritance are known to cause CLN13: six missense mutations (p.Gln321Arg, p.Gly458Ala, p.Ser480Leu, p.Tyr231Cys, p.Ile404Thr, and p.Cys326Phe), a nonsense mutation c.416C > A (p.S139*), a frameshift mutation (p.Ser319Leufs*27), and a mutation preventing the correct splicing of CTSF mRNA (c.213 + 1G>C) [134][135][136][137]. It has been shown that disease-causing CTSF mutants fail to cleave the lysosomal integral membrane protein type-2 (LIMP-2/SCARB2) required for normal biogenesis and maintenance of lysosomes and endosomes [138,139]; however, the exact mechanism by which CTSF deficiency translates in the clinical onset of CLN13 remains elusive. The biochemical and molecular mechanisms underlying NCLs have not been addressed yet.…”
Section: Gene Deficiency Biological Effect Referencesmentioning
confidence: 99%
“…Previous studies demonstrated that missense mutations in the CTSF gene caused Type B Kufs disease. Patients showed progressive neurodegeneration and accumulation of abnormal lipopigments in the brain and presented dementia and motor disturbances (Peters et al, 2015; Smith et al, 2013). However, disease mechanisms linking mutations in the CTSF gene to neurodegeneration and intralysosomal storage are still unclear.…”
Section: Discussionmentioning
confidence: 99%
“…However, CTSF expression levels were higher in several human cancer cell lines than in normal cells (Vazquez-Ortiz et al, 2005) suggesting that CTSF could play an important role in carcinogenesis. Moreover, previous studies have shown that mutations in the CTSF gene are associated with Type B Kufs disease, an adult form of neuronal ceroid lipofuscinosis (Peters et al, 2015; Smith et al, 2013). The present study aimed to identify and characterize the Alu -derived exonization events in the CTSF gene of the rhesus monkey ( Macaca mulatta ) and the crab-eating monkey ( Macaca fascicularis ).…”
Section: Introductionmentioning
confidence: 99%